Detail Information of Genetic Polymorphisms
General Information of Drug Transporter (DT) | |||||
---|---|---|---|---|---|
DT ID | DTD0422 Transporter Info | ||||
Gene Name | SLC5A2 | ||||
Protein Name | Sodium/glucose cotransporter 2 | ||||
Gene ID | |||||
UniProt ID | |||||
Genetic Polymorphisms of DT (GPD) | |||||
Genetic Polymorphism | rs11646054 | ||||
Site of GPD | chr16:31484350 (GRCh38.p12) | ||||
GPD Type | SNP | ||||
Allele(s) in dbSNP | G>A / G>C / G>T | ||||
Minor Allele Frequency | G=0.6990/1383 (Global) | ||||
Allele C | Click to Show/Hide the Full List of Affected Drugs: 1 Drugs in Total | ||||
Empagliflozin | N.A. | Alcohol Abuse | Allele C is not associated with response to empagliflozin in people with Diabetes Mellitus, Type 2 as compared to allele G. | [ 1] | |
Genetic Polymorphism | rs3116149 | ||||
Site of GPD | chr16:31484405 (GRCh38.p12) | ||||
GPD Type | SNP | ||||
Allele(s) in dbSNP | G>A | ||||
Minor Allele Frequency | G=0.8990/1779 (Global) | ||||
Allele A | Click to Show/Hide the Full List of Affected Drugs: 1 Drugs in Total | ||||
Empagliflozin | N.A. | Alcohol Abuse | Allele A is not associated with response to empagliflozin in people with Diabetes Mellitus, Type 2 as compared to allele G. | [ 1] | |
Genetic Polymorphism | rs3116150 | ||||
Site of GPD | chr16:31486700 (GRCh38.p12) | ||||
GPD Type | SNP | ||||
Allele(s) in dbSNP | G>A | ||||
Minor Allele Frequency | G=0.9020/1785 (Global) | ||||
Allele A | Click to Show/Hide the Full List of Affected Drugs: 1 Drugs in Total | ||||
Empagliflozin | N.A. | Alcohol Abuse | Allele A is not associated with response to empagliflozin in people with Diabetes Mellitus, Type 2 as compared to allele G. | [ 1] | |
Genetic Polymorphism | rs9924771 | ||||
Site of GPD | chr16:31484256 (GRCh38.p12) | ||||
GPD Type | SNP | ||||
Allele(s) in dbSNP | A>G / A>T | ||||
Minor Allele Frequency | A=0.3340/660 (Global) | ||||
Allele A | Click to Show/Hide the Full List of Affected Drugs: 1 Drugs in Total | ||||
Empagliflozin | N.A. | Alcohol Abuse | Allele A is not associated with response to empagliflozin in people with Diabetes Mellitus, Type 2 as compared to allele G. | [ 1] | |
Genetic Polymorphism | rs3813008 | ||||
Site of GPD | chr16:31486560 (GRCh38.p12) | ||||
GPD Type | SNP | ||||
Allele(s) in dbSNP | G>A / G>C | ||||
Minor Allele Frequency | G=0.8210/1624 (Global) | ||||
Allele A | Click to Show/Hide the Full List of Affected Drugs: 1 Drugs in Total | ||||
Empagliflozin | N.A. | Alcohol Abuse | Allele A is not associated with response to empagliflozin in people with Diabetes Mellitus, Type 2 as compared to allele G. | [ 1] | |
References | |||||
1 | Influence of common polymorphisms in the SLC5A2 gene on metabolic traits in subjects at increased risk of diabetes and on response to empagliflozin treatment in patients with diabetes. Pharmacogenet Genomics. 2017 Apr;27(4):135-142. |
If you find any error in data or bug in web service, please kindly report it to Dr. Li and Dr. Fu.